Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-049987
Filing Date
2022-09-14
Accepted
2022-09-14 19:32:24
Documents
2
Period of Report
2022-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2214
2 POA DOCUMENT poa.txt EX-24 2901
  Complete submission text file 0001209191-22-049987.txt   6637
Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Nicholson Garry A (Reporting) CIK: 0001640861 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40431 | Film No.: 221244190

Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations